PROLACTIN RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN NORMAL AND NEOPLASTIC HUMAN PITUITARY TISSUES

Citation
L. Jin et al., PROLACTIN RECEPTOR MESSENGER-RIBONUCLEIC-ACID IN NORMAL AND NEOPLASTIC HUMAN PITUITARY TISSUES, The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 963-968
Citations number
37
Categorie Soggetti
Endocrynology & Metabolism
ISSN journal
0021972X
Volume
82
Issue
3
Year of publication
1997
Pages
963 - 968
Database
ISI
SICI code
0021-972X(1997)82:3<963:PRMINA>2.0.ZU;2-5
Abstract
We examined the specific cell types in normal human pituitaries that e xpressed PRL receptor (PRL-R) messenger ribonucleic acid (mRNA) by com bined in situ hybridization and immunohistochemistry. The distribution of PRL-R mRNA in 28 pituitary adenomas was examined by in situ hybrid ization and reverse transcription-PCR in 12 cases of adenomas. In anot her set of experiments, 34 PRL adenomas fi om men, women, and bromocri ptine-treated patients were analyzed for PRL-R by in situ hybridizatio n. In the normal pituitary, PRL- and LH-producing cells had significan tly more mean grain counts per cell and higher percentages of cells po sitive for PRL-R than GH and TSH cells. PRL-R mRNA was present in all groups of adenomas by in situ hybridization and reverse transcription- PCR. PRL adenomas had a significantly higher density of labeling compa red to other adenoma types. Although there was no difference in the le vels of PRL-R mRNA in PRL adenomas from men and premenopausal and post menopausal women, patients treated with bromocriptine before pituitary surgery had significantly lower levels of PRL-R compared to all other groups. These results indicate that in the normal pituitary, PRL and LH cells have the highest level of PRL-R mRNA, whereas PRL adenomas ha ve significantly higher levels of PRL-R mRNA than other types of adeno mas, and bromocriptine treatment decreases the levels of PRL-R mRNA in PRL adenomas.